A calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP of the European Pharmacopoeia monograph is often referred to as a calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate Certificate of Suitability (COS). The purpose of a calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate to their clients by showing that a calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP has been issued for it. The manufacturer submits a calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP (COS) as part of the market authorization procedure, and it takes on the role of a calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP holder for the record. Additionally, the data presented in the calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate DMF.
A calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate suppliers with CEP (COS) on PharmaCompass.